Intracranial injection of AAV expressing NEP but not IDE reduces amyloid pathology in APP+PS1 transgenic mice.
The accumulation of β-amyloid peptides in the brain has been recognized as an essential factor in Alzheimer's disease pathology. Several proteases, including Neprilysin (NEP), endothelin converting enzyme (ECE), and insulin degrading enzyme (IDE), have been shown to cleave β-amyloid peptides (A...
Saved in:
Main Authors: | Nikisha Carty, Kevin R Nash, Milene Brownlow, Dana Cruite, Donna Wilcock, Maj-Linda B Selenica, Daniel C Lee, Marcia N Gordon, Dave Morgan |
---|---|
Format: | article |
Language: | EN |
Published: |
Public Library of Science (PLoS)
2013
|
Subjects: | |
Online Access: | https://doaj.org/article/c61b562f15eb4169a63bb0f3b5b93a3e |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Author Correction: Untargeted lipidomics reveals progression of early Alzheimer’s disease in APP/PS1 transgenic mice
by: Xueju Zhang, et al.
Published: (2021) -
Epigenetic mechanisms underlying the effects of triptolide and tripchlorolide on the expression of neuroligin-1 in the hippocampus of APP/PS1 transgenic mice
by: Xiaomei Lu, et al.
Published: (2019) -
Tripchlorolide attenuates β-amyloid generation by inducing NEP activity in N2a/APP695 cells
by: Zeng Yuqi, et al.
Published: (2021) -
Downregulating expression of OPTN elevates neuroinflammation via AIM2 inflammasome- and RIPK1-activating mechanisms in APP/PS1 transgenic mice
by: Long-Long Cao, et al.
Published: (2021) -
Histone Deacetylase 2 Knockdown Ameliorates Morphological Abnormalities of Dendritic Branches and Spines to Improve Synaptic Plasticity in an APP/PS1 Transgenic Mouse Model
by: Daiki Nakatsuka, et al.
Published: (2021)